🎙️ Episode 23: Hot Flash Fix: Fezolinetant Makes Menopause Manageable

Brilliant Board Review & CME
20/04/2025 1 min Temporada 1 Episodio 23
🎙️ Episode 23: Hot Flash Fix: Fezolinetant Makes Menopause Manageable

Listen "🎙️ Episode 23: Hot Flash Fix: Fezolinetant Makes Menopause Manageable"

Descargar episodio

Episode Synopsis

Send us a text🧠 Problem:80% of menopausal women suffer from vasomotor symptoms (hot flashes, night sweats).Many can't take hormone therapy (VTE, CAD, breast CA).💊 Fezolinetant:NK3 receptor antagonist — first in class.Reduces frequency and intensity of hot flashes.Safe in patients who can’t take estrogen.⚠️ Side Effects:GI symptoms, transaminitis.Requires liver function monitoring.🧩 Clinical Takeaway:A breakthrough for non-hormonal menopause management.Ideal for patients at high risk or contraindications to HRT.

More episodes of the podcast Brilliant Board Review & CME

🎙️ Episode 45: Mind the Gap – Perioperative Pearls for Older Adults 21/04/2025
🎙️ Episode 44: Thiazide Throwdown: HCTZ vs Chlorthalidone in Real Life 21/04/2025
🎙️ Episode 43: GLP-1s Under the Knife – A Gut Check on Surgery Risks 21/04/2025
🎙️ Episode 42: DOACs Decoded: When to Dabble, When to Dodge 21/04/2025
🎙️ Episode 41: Stairway to Surgery: Cardiac Clues Before the Cut 21/04/2025
🎙️ Episode 40: Anticoag After Ischemic Stroke: Sooner May Be Safer 20/04/2025
🎙️ Episode 39: Vitamin K2: The Leg Cramp Secret? 20/04/2025
🎙️ Episode 38: TXA for ICH: Not the Magic Bullet 20/04/2025
🎙️ Episode 37: Transfusions in SAH: 8 or 10? Pick 8 20/04/2025
🎙️ Episode 36: Mitral Valve 2.0: Transcatheter Repair Steps Up 20/04/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA